about
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case reportRole of apoptosis in diseasePseudomembranous colitisNovel strategies for enhanced removal of persistent Bacillus anthracis surrogates and Clostridium difficile spores from skinInduced sporicidal activity of chlorhexidine against Clostridium difficile spores under altered physical and chemical conditionsUnlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical ConditionsClostridium difficile infection: Updates in management.Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteriaClostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2.A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027.Spores of Clostridium difficile clinical isolates display a diverse germination response to bile saltsToxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern SwitzerlandUtility of Clostridium difficile toxin B for inducing anti-tumor immunity.Activate to eradicate: inhibition of Clostridium difficile spore outgrowth by the synergistic effects of osmotic activation and nisinExpanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles.Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature.Proteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome.Clostridium difficile-associated diarrhea in adultsPathogenesis and treatment of Clostridium difficile infectionThe emergence of Clostridium difficile as a pathogen of food animals.The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.Wall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile.Clostridium difficile infection in patients with HIV/AIDS.Detecting the dormant: a review of recent advances in molecular techniques for assessing the viability of bacterial endospores.A Cumulative Spore Killing Approach: Synergistic Sporicidal Activity of Dilute Peracetic Acid and Ethanol at Low pH Against Clostridium difficile and Bacillus subtilis SporesCo-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature.Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.Is the interleukin 8 promoter polymorphism rs4073/-251T >A associated with Clostridium difficile infection?A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.Bacteriophage-encoded toxins: the lambda-holin protein causes caspase-independent non-apoptotic cell death of eukaryotic cells.A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein.SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate.Mapping interactions between germinants and Clostridium difficile spores.Sensitizing Clostridium difficile Spores with Germinants on Skin and Environmental Surfaces Represents a New Strategy for Reducing Spores via Ambient Mechanisms.Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells.Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores.Effect of natural products on the production and activity of Clostridium difficile toxins in vitro
P2860
Q24801192-076AFB66-0A50-440E-B10F-C543C9DF8E1DQ26865637-BFC67C04-95E2-4F08-A836-60F8ABB065A0Q26865999-58C25092-117F-4E2C-9C68-DEE1F2615A51Q28385028-708A8DD8-68A9-49FD-A793-B67B5BE2155FQ28546073-B1A95892-DAD0-4A0A-A4C3-BA6CE49617F5Q28546550-61565DAE-DD46-430F-9729-0565F9E6D1D0Q30239988-FD8CB80E-8820-47B1-956E-9024A44D25ADQ33509392-4541D8C2-150F-49AD-A3A1-D6CC25C3D7ACQ33860004-4F2DD259-03F3-4E7C-A8E4-23B3AB3ACEEEQ33954369-ED635483-A4A8-4879-A82D-3CE8986CA603Q34031580-6FC868FE-E0A1-45F0-8013-8DDF06075C6EQ34182639-8C3DEC51-8D60-47AB-BC5A-AED19A95A367Q34338268-109CC726-51DB-4E23-8485-BC42EA6C7D04Q34395494-C66B65E8-5994-4368-83DE-CA9D2F8021F9Q34563437-E8DDE2F8-0CE1-41AB-9788-FF72BE5AE525Q34584691-719D4F07-BAEF-4257-9ACF-CDAE40EF14CCQ34853584-9A3D8C1A-E3B7-49F1-865A-BDBF9148F308Q35798768-FB42E539-B229-4FD8-A3C9-1B8047D8BC07Q35828291-11FE6D64-D5DC-4AA5-BFD3-7D453288879DQ36152528-7AFE61DD-9BA2-4A87-8380-30A56E35778FQ36177434-D13E6C62-E2F8-4301-9E20-A403CDC0ECB5Q36283755-69F4B4C9-8A09-4432-B82B-8949E1B11925Q37009989-F4E8B5E1-D083-4A95-BAD6-EE8D957EAD44Q37348810-C41C8CF5-1FC6-470B-BBB4-C5E52AF1C77EQ38105281-6D92FFFC-588C-4906-9B6E-E232B04736C2Q38126311-0758205F-4359-4374-8A78-951D17B7AD41Q38377359-286504CE-6559-49D1-9CA2-34B4F4F87689Q38450492-26379586-A552-47E4-916F-5401683E9751Q38755916-A9B46818-62DB-4FE6-ABCD-11FD30C54545Q39255777-60BD6D74-7EA4-4FA5-9336-3671CBD72EB6Q39434182-5ECA28A3-04D6-4392-A281-747CAFD0C9ABQ40130108-8BBA25C8-9DEC-4B49-AB2B-E9C728C8E813Q40161828-9A3E40E0-414D-4E4C-9EBD-2EDA09B5DC48Q41810467-D8125461-0096-4CB1-AE4E-FA5A9F8E49A0Q41948068-0D322A6D-0D43-4199-B1B9-0D75F8C47AF9Q42165855-1E377F76-899E-47EA-AC38-E381C1CAE22AQ44995808-0A5B428D-90C3-424B-8BA2-8ECB73357FAAQ52639383-9247FC1C-23AF-450C-9E4C-546F0C64CB0FQ54391317-027A6139-3E78-4EFB-8CEE-8C32E9E4897EQ57794611-D9F15017-5098-4FBE-975F-CEE5932BB29C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The pathogenicity of Clostridium difficile.
@ast
The pathogenicity of Clostridium difficile.
@en
The pathogenicity of Clostridium difficile.
@nl
type
label
The pathogenicity of Clostridium difficile.
@ast
The pathogenicity of Clostridium difficile.
@en
The pathogenicity of Clostridium difficile.
@nl
prefLabel
The pathogenicity of Clostridium difficile.
@ast
The pathogenicity of Clostridium difficile.
@en
The pathogenicity of Clostridium difficile.
@nl
P1476
The pathogenicity of Clostridium difficile
@en
P2093
I R Poxton
J McCoubrey
P304
P356
10.1046/J.1198-743X.2001.00287.X
P50
P577
2001-08-01T00:00:00Z